Beyond gastrointestinal symptom burden
Integrating fecal calprotectin into a multimodal safety strategy before initiating bimekizumab in hidradenitis suppurativa.
Du W, Chen H
Journal of the American Academy of DermatologyIn the feed 11 Aug 2026, published online 11 Aug 2026, issue 2026 Aug 11, added to PubMed 11 Aug 2026
Topics: Hidradenitis suppurativaDrug reactionsSkin biologyBiologics
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42580418 · DOI 10.1016/j.jaad.2026.05.143